- Sartorius to open new state-of-the-art manufacturing facility in UK
- Joysbio develops kit for verifying antibodies after vaccination
- Exyte to build diabetes care player Dexcom's first manufacturing facility in Asia
- Korean firm Seegene expands influence in Italy's PCR diagnostic industry
- Japan invents novel cell therapy for type I diabetes mellitus
- Sanofi and C4X Discovery ink €414 M worldwide licensing deal
- Radcliffe Cardiology launches cardiovascular disease journal for APAC region
- Japan boosts native life science biz via virtual access for global audience
- AbbVie and Pfizer lead rheumatoid arthritis digital marketing space in Australia
- Korea's Single-cell analysis services to offer tumor genome profiling to researchers
- Singapore develops innovative non-integrating CAR T vector system
- Japanese–European research team discovers novel genetic mitochondrial disorder
- OMRON Hypertension Plus enables remote patient monitoring in the UK
- Lonza expands automated robotic solution for endotoxin testing
-
Specials | 07 April 2021 | Influencers
China and India... to play a vital role in supplying COVID-19 vaccines globally
1. What are the other contributions Avantor is making to fight this pandemic, particularly in APAC? &...Read more
Specials | 28 February 2021 | Influencers
1.What have been your key contributions within the organization towards fighting covid-19? The curren...Read more
-
Europe | 17 February 2021 | News
Merck designs sustainability framework offering data-driven insights
Merck, a leading science and technology company, has launched an enhanced Design for Sustainability (Df...Read more
-
World | 12 February 2021 | News
GenScript receives FDA EUA to use cPass test in convalescent plasma screening
GenScript USA Inc., the world's leading life science research tools and services provider, announced today tha...Read more
World | 10 February 2021 | News
Globally 128 million COVID-19 vaccine doses administered so far, updates WHO
WHo at a media briefing on Feb 10, 2021, updated that globally around 128 million vaccine doses administered s...Read more
-
Australia | 12 February 2021 | News
Australia offers revolutionary new treatment for antibiotic resistance
SuperTrans Medical (STM), a biopharmaceutical company developing novel antibiotics that target difficult-to-tr...Read more
-
World | 11 January 2021 | News
PerkinElmer to acquire Oxford Immunotec for $591M
PerkinElmer, Inc. and Oxford Immunotec Global PLC have reached an agreement on terms under which Per...Read more
BIG PHARMA RE-HASH MEDICAL MARIJUANA
Known to the world by many names, Marijuana, Cannabis, MJ, Pot, weed or Ganjika in Sanskrit and Ganja in Hindi, this ancient plant has been known to the ancient Indians and Chinese for its medicinal benefits. Ayurvedic texts known as Samhitas have extolled the many benefits of this widely available green wonder. Yet, due to misconceptions, willful or otherwise had shrouded it for many centuries. While there are numerous medicinal properties that can be applied, misuse of the plant could also have disastrous consequences, especially if used as an addictive derivative. The global medical cannabis market is set to reach $3.2 billion by 2025, according to GlobalData. With big pharma taking notice and interest in the sector, the cannabis industry is at the brink of a revolution. BioSpectrum deep dives in to the fascination of big pharma in the cannabis space, how will this disrupt the cannabis industry and most importantly how the pharmaceutical cannabis sector should be regulated?
For Feedback Email Us : communications@biospectrumasia.com
